BioSpace News Archive

Constellation Brands, Inc. (Constellation) (NYSE: STZ) (NYSE: STZ.B) and Canopy Growth Corporation (Canopy Growth or the Company) (TSX: WEED) (NYSE: CGC) today announced the closing of Constellation’s $5 billion CAD ($4 billion USD) investment in Canopy Growth, which was previously announced on August 15, 2018.

Wellspring celebrated its compounding pharmacy division’s grand opening with a ribbon cutting attended by over 60 guests, including Berkeley Mayor Jesse Arreguín, on Tuesday, October 30th at its new location.

- On Sunday, Nov. 4, the Shirley Ryan AbilityLab (formerly Rehabilitation Institute of Chicago) will host SkyRise Chicago at Willis Tower for the tenth consecutive year.

The California Telehealth Network (CTN), under the OCHIN Family of Companies, received federal funds to launch the Opioid and Chronic Pain Telemedicine Project across seven rural counties in Northern California.

BioArctic AB announced today that the company has received a Notice of Option Exercise under the Research, Development, Option and License Agreement dated as of September 15, 2016 between AbbVie (NYSE: ABBV) and BioArctic.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced third quarter 2018 financial results.

– New Commitment by Great Point Partners Brings Proceeds of Transactions to $87 Million –

Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome

Study shows retail clinics deliver on satisfaction and convenience, but they are an additional channel, rather than a complete substitute, for primary care

In conjunction with DURECT Corporation’s (Nasdaq: DRRX) third quarter 2018 financial results press release, you are invited to listen to a conference call that will be broadcast live over the internet on Wednesday, November 7, 2018 at 4:30 pm Eastern Time (1:30 pm Pacific Time).